Funding for this research was provided by:
NIHR School for Primary Care Research (SPCR-2014-10043 413 and SPCR-2014-10043 417)
National Institute for Health Research (Collaboration for Leadership in Applied Health Research, BRC, Senior Investigator award, Evidence synthesis working group (project 390))
Oxford Health NHS Foundation Trust (Care Oxford)
Indena S.p.A (Supplying cranberry capsules)
Received: 20 August 2019
Accepted: 28 October 2019
First Online: 23 December 2019
Ethics approval and consent to participate
: Informed consent will be obtained from participants prior to entry into the study. In accordance with the Declaration of Helsinki, the CUTI study has been submitted to, and approved by, the South Central Oxford B Ethics Committee (REC reference: 18/SC/0673), the Health Research Authority (IRAS Project ID: 249672) and has received confirmation of capability and capacity through the local Clinical Research Network for each participating site prior to entering patients into the study.
: Not applicable
: OG is funded by the National Institute for Health Research (NIHR) School for Primary Care Research (SPCR) and the Wellcome Trust.CB reports receiving advisory board fees from Roche Molecular Systems and grant support from Roche Molecular Diagnostics; CB was supported by funding from an NIHR Protection Research Unit on Health Care Associated Infections and Antimicrobial Resistance, by the NIHR MedTech and In Vitro Diagnostics Co-operative at Oxford NHS Foundation Trust, and by an NIHR Senior Investigator Award.CH holds grant funding from the NIHR School of Primary Care Research Evidence Synthesis Working Group (project 390) and the NIHR Oxford BRC. He is Editor-in-Chief of <i>BMJ Evidence-Based Medicine</i> and an NIHR Senior Investigator.AH, AMB, JA, MM and NW have no competing interests.Indena S.p.A is supplying cranberry capsules for the study free of charge and has no other involvement with the study.